Overview
NXL market data
Price History
NXL price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for NXL. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
8-K filing — Nexalin Technology, Inc. (NXL)SEC EDGAR · Jun 17, 2026, 9:00 PM
Nexalin Technology To Present Clinical Data Showing 77.8% Anxiety Response Rate, Durable 8-Week Benefits, And No Serious Adverse Events From Its 15 mA, 77.5 Hz DIFS Deep-Brain Stimulation Platform, At 2026 NYC Neuromodulation ConferenceBenzinga · Jun 16, 2026, 1:25 PM
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and InsomniaGlobenewswire Inc · Jun 4, 2026, 2:15 PM
Nexalin Technology Announces New U.S. Patent Covering Dynamic Frequency Deep-Brain Neurostimulation For Anxiety, Depression, And Insomnia TreatmentBenzinga · Jun 4, 2026, 2:05 PM
Nexalin Technology Secures Key Neurostimulation Legislative Provision In Appropriations Bill Passed By U.S. House Of RepresentativesBenzinga · May 21, 2026, 12:40 PM
Nexalin Technology Acquires Digital Health Platform PONM From GreenLight Ventures; Financial Terms Not DisclosedBenzinga · May 19, 2026, 12:40 PM